Here are the recap for the top 3 major gainers in the biotech sector on Thursday. keep an eye on the following stocks.
Syros Pharmaceuticals (NASDAQ:SYRS) was one of the major gainers as the stock closed higher by 96 cents or 17.17% to $6.55. Total volume was 9.35 million shares, compared to its 30-day average volume of 1.02 million shares. The stock moved within a range of $5.82 – 7.03 after opening at $5.91. The stock has fallen almost 31% over the past year. The stock got a boost as analyst at Oppenheimer started coverage on the stock with a buy rating and set a price target of $13.
Prothena Corporation plc (NASDAQ:PRTA) was another stock that got special attention as the stock made a new high and closed higher by 14.14% to $30.43 on the volume of 745K shares, compared to its daily average volume of 372K shares. Moreover, the stock made a new high of $30.62. In yesterday’s trading session, the stock made a high and low of $30.62 and $26.07 respectively. Over the past year, the stock has moved up 173%. The stock is trading near to the oversold zone as RSI stands above 71.
Inhibrx, Inc (NASDAQ:INBX) continued to move higher and extended weekly gains. On Thursday, stock has gained by $2.29 or 11.58% to end the session at $22.07. After opening at $19.78, the stock has moved within a wide range of $14.27 – 50.97. Over the past 52-week, the stock moved within a range of $1.0300 – 7.4500. The stock has fallen 13% in the past quarter. The stock is trading 57% below its 52-week high and 54.50% higher from its 52-week low.
